Is preclinical autoimmunity benign?: The case of cardiovascular disease.

Related Articles

Is preclinical autoimmunity benign?: The case of cardiovascular disease.

Rheum Dis Clin North Am. 2014 Nov;40(4):659-68

Authors: Majka DS, Chang RW

Abstract
Although there are many examples of autoantibodies in disease-free individuals, they can be a preclinical phenomenon heralding future autoimmune rheumatic disease. They may be a marker for autoreactive B-cell activation and other inflammatory autoimmune processes. The increased prevalence of cardiovascular disease (CVD) in autoimmune rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus, and the increased risk of CVD in patients with rheumatic disease with autoantibodies, suggest that CVD may have autoimmune features. Autoantibodies might be risk markers for subclinical and clinical CVD development not only in patients with rheumatic diseases but in the general population as well.

PMID: 25437283 [PubMed - indexed for MEDLINE]